217 related articles for article (PubMed ID: 36254503)
1. An Australian perspective on antimicrobial stewardship programs and transplantation.
Stewart AG; Isler B; Paterson DL
Transpl Infect Dis; 2022 Oct; 24(5):e13912. PubMed ID: 36254503
[TBL] [Abstract][Full Text] [Related]
2. Antifungal stewardship in solid-organ transplantation: What is needed?
Whitney L; Armstrong-James D; Lyster HS; Reed AK; Dunning J; Nwankwo L; Cheong J
Transpl Infect Dis; 2022 Oct; 24(5):e13894. PubMed ID: 36254506
[TBL] [Abstract][Full Text] [Related]
3. The increasing problem of treatment-resistant fungal infections: a call for antifungal stewardship programs.
Gupta AK; Venkataraman M; Renaud HJ; Summerbell R; Shear NH; Piguet V
Int J Dermatol; 2021 Dec; 60(12):e474-e479. PubMed ID: 33729567
[TBL] [Abstract][Full Text] [Related]
4. How can we optimise antifungal use in a solid organ transplant centre? Local epidemiology and antifungal stewardship implementation: A single-centre study.
Mularoni A; Adamoli L; Polidori P; Ragonese B; Gioè SM; Pietrosi A; Tuzzolino F; Guadagnino G; Monaco F; Grossi PA; Conaldi PG; Luca A; Mikulska M
Mycoses; 2020 Jul; 63(7):746-754. PubMed ID: 32358860
[TBL] [Abstract][Full Text] [Related]
5. Antifungal stewardship considerations for adults and pediatrics.
Hamdy RF; Zaoutis TE; Seo SK
Virulence; 2017 Aug; 8(6):658-672. PubMed ID: 27588344
[TBL] [Abstract][Full Text] [Related]
6. [Inappropriate antifungal prescription and the need for antifungal stewardship programs].
Osorio-Lombana JP; Cuervo-Maldonado SI; López-Mora MJ; Gómez-Rincón JC
Rev Chilena Infectol; 2019 Aug; 36(4):403-413. PubMed ID: 31859762
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the impact of antifungal stewardship interventions in the United States.
Hart E; Nguyen M; Allen M; Clark CM; Jacobs DM
Ann Clin Microbiol Antimicrob; 2019 Aug; 18(1):24. PubMed ID: 31434563
[TBL] [Abstract][Full Text] [Related]
8. Current state of antimicrobial stewardship in solid organ transplantation in Israel.
Hoffman T; Atamna A; Katchman E; Orenbuch-Harroch E; Nesher L; Bitterman R; Yahav D; Nutman A
Transpl Infect Dis; 2022 Oct; 24(5):e13875. PubMed ID: 36254513
[TBL] [Abstract][Full Text] [Related]
9. Current State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States.
Seo SK; Lo K; Abbo LM
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1195-200. PubMed ID: 27457099
[TBL] [Abstract][Full Text] [Related]
10. The time is now: antimicrobial stewardship in solid organ transplantation.
Hand JM
Curr Opin Organ Transplant; 2021 Aug; 26(4):405-411. PubMed ID: 34039881
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Use of Novel Biomarkers to Augment Antimicrobial Stewardship Program Activities.
Stover KR; Kenney RM; King ST; Gross AE
Pharmacotherapy; 2018 Feb; 38(2):271-283. PubMed ID: 29245184
[TBL] [Abstract][Full Text] [Related]
12. White paper on antimicrobial stewardship in solid organ transplant recipients.
So M; Hand J; Forrest G; Pouch SM; Te H; Ardura MI; Bartash RM; Dadhania DM; Edelman J; Ince D; Jorgenson MR; Kabbani S; Lease ED; Levine D; Ohler L; Patel G; Pisano J; Spinner ML; Abbo L; Verna EC; Husain S
Am J Transplant; 2022 Jan; 22(1):96-112. PubMed ID: 34212491
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial stewardship in pediatric solid organ transplantation: Is it possible?
Kitano T; Allen U
Transpl Infect Dis; 2022 Oct; 24(5):e13928. PubMed ID: 35980210
[TBL] [Abstract][Full Text] [Related]
14. Opportunities for Antimicrobial Stewardship Interventions Among Solid Organ Transplant Recipients.
Stohs EJ; Gorsline CA
Infect Dis Clin North Am; 2023 Sep; 37(3):539-560. PubMed ID: 37280135
[TBL] [Abstract][Full Text] [Related]
15. Current state of antimicrobial stewardship in organ transplantation in Singapore.
Chung SJ; Liew Y; Lee WHL; Kwa ALH; Tan TT; Tan BH
Transpl Infect Dis; 2022 Oct; 24(5):e13886. PubMed ID: 35751866
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Stewardship Programs in Children: Challenges and Opportunities.
Kourti M; Chorafa E; Roilides E; Iosifidis E
Pediatr Infect Dis J; 2023 Jul; 42(7):e246-e248. PubMed ID: 37257114
[No Abstract] [Full Text] [Related]
17. Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program.
Paige E; Haywood P; Xie M; Worth L; Thursky K; Urbancic K; Bajel A; Slavin M
Leuk Lymphoma; 2019 Oct; 60(10):2373-2383. PubMed ID: 31096813
[TBL] [Abstract][Full Text] [Related]
18. Practical checklist for implementation of antifungal stewardship programmes.
Bienvenu AL; Pavese P; Leboucher G; Berger P; Roux S; Charmillon A; Foroni L; Menotti J; Lebeaux D; Mayan R; Mondain V; Robin C; Lesprit P; Alfandari S; Kernéis S
J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35771615
[No Abstract] [Full Text] [Related]
19. Antifungal stewardship with an emphasis on candidaemia.
Capoor MR; Subudhi CP; Collier A; Bal AM
J Glob Antimicrob Resist; 2019 Dec; 19():262-268. PubMed ID: 31195147
[TBL] [Abstract][Full Text] [Related]
20. The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan.
Kawaguchi H; Yamada K; Imoto W; Yamairi K; Shibata W; Namikawa H; Yoshii N; Nakaie K; Okada Y; Fujita A; Shinoda Y; Nakamura Y; Kaneko Y; Nagayama K; Kakeya H
J Infect Chemother; 2019 Jun; 25(6):458-462. PubMed ID: 30803878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
